Biohit Oyj - Financial Calendar

Biohit's Financial Reporting and Annual General Meeting in 2013

Biohit will release its financial statements for 2012 on Wednesday 27nd of
February 2013 at 9:30 AM. 

Biohit Oyj's Annual General Meeting has been planned for Monday 8th of April
2013 at 3:00 PM in Helsinki, Finland. The Board of Directors will call the
General Meeting at a later date. 

Company will publish three interim reports in 2013, based on the following
schedule: 

  -- Interim report for period January - March 2013 (Q1) on Thursday 25th of
     April 2013 at 9:30 AM.
  -- Interim report for period January - June 2013 (Q2) on Thursday 8th August
     2013 at 9:30 AM.
  -- Interim report for period January - September 2013 (Q3) on Thursday 24th
     October 2013 at 9:30 AM.

The published economic reports and other stock exchange releases will be
available on Biohit's website at www.biohithealthcare.com/investors. The
website also contains an online form for ordering electronic copies, which will
be e-mailed to you. 



For further details:

CEO Semi Korpela
Tel. +358 9 773 861
semi.korpela@biohit.fi
www.biohithealthcare.com





Biohit Oyj is a Finnish biotechnology company operating globally that was
established in 1988. Biohit's mission is “Innovating for Health” and “Cancer
Prevention”. The purpose of the company is to take social responsibility and
produce innovation, new technologies and analysis systems for use in medicine,
research institutions and industry, helping to promote research and diagnostics
and to improve the quality of life of people by means of preventing disease,
human suffering and financial loss. We are committed to responsibility and it
is our duty to innovate and develop the marketing and availability of our
products and services. Biohit is headquartered in Helsinki and its subsidiaries
are located China and UK. Since 1999, Biohit's Series B shares (BIOBV) have
been listed in the NASDAQ OMX Helsinki Oy Small cap/Healthcare sector.